🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Phenomenal talk by the legendary Dr. Hirsh on what makes a successful research career Hamilton Health Sciences research symposium with @ECRI_RESEARCH McMaster Research

And so it begins…our first myeloma march fundraising event-Bring your Pride! with Hamilton Health Sciences Myeloma Canada Canadian Myeloma Research Group McMaster Research Chris Hillis Neil Johnson 🇨🇦 Dr. Tom Kouroukis Wendy Mair Bursey 🇨🇦 Dr. Tobias Berg Gwynivere Davies

Great work by our Juravinski team. Myeloma is a devastating disease and the research we are doing brings hope for those with the disease. It’s personal for me as a close family member is living with myeloma. Go team. Working with Myeloma Canada we will make a difference

Friendly reminder of our #CDCRSeminarSeries tomorrow at 4pm in MDCL 3020 or on Zoom! We look forward to seeing you.

A team of Canadian and American researchers co-led by Sheila Singh Brain Tumour Lab and The Hospital for Sick Children (SickKids) have developed a promising therapy treatment that can kill glioblastoma cells in newly discovered pathway. CIHR NRC Canada UVA University of Pittsburgh Princess Margaret Cancer Centre ow.ly/XWbz50SQ4H9

Congratulations Hira Mian on your new role as the ArcelorMittalDofasco Chair in Cancer Therapeutics Research Hamilton Health Sciences Hamilton Health Sciences Foundation #CancerResearch

ASAP continues: No need for remission induction in primary refractory or first relapse AML as it increases toxicity, hospital stay, costs. Patients can proceed to transplant, need to work on sequential conditioning, have donors ready! #Leusm #ASH23

What a way to end ASH, huge late breaking presentation from a huge Canadian superstar 🇨🇦

Heartfelt thanks to everyone at HHS and the HHS Foundation for helping us make research an integral part of our care. Your ongoing support fuels our mission to beat blood cancers and other diseases. #ResearchisCare hamiltonhealth.ca #vital2HHS

Thank you for the opportunity to present our data at #ASH2024 in #SanDiego! Emily delivered an outstanding poster presentation, and we’re so proud of her excellent work and dedication. Thank you to the community for the valuable discussions and feedback! #Hematology

Congrats to Rolles et al. and the VALIDATE Consortium! At #ASH2024, they showed that achieving CR before alloHCT doesn’t add survival benefit post-transplant for MDS patients. Performing the transplant and its timing matter most. #MDS #AlloHCT #Hematology

Canadian consensus guidelines on MRD testing in Canada...Bottom line: we need access to publicly funded MRD testing for our MM patients across Canada with Myeloma Canada Canadian Myeloma Research Group Hamilton Health Sciences McMaster University doi.org/10.1016/j.clml…

Thanks to the #JuravinskiLegacy, researchers at Hamilton Health Sciences, McMaster University and @STJOESHAMILTON are simplifying how biological samples are collected and managed for research. Learn more ➡️ juravinskiresearchinstitute.ca/biospecimen

Thanks to the #JuravinskiLegacy, researchers at Hamilton Health Sciences, McMaster University and @STJOESHAMILTON are simplifying how biological samples are collected and managed for research. Learn more at bit.ly/4kmbsnd Sheila Singh Brain Tumour Lab PHRI.ca Population Health Research Institute 🇨🇦 McMaster Health Sciences The Research Institute of St. Joe's Hamilton

A Hamilton Health Sciences study found that detecting 'mixed chimerism' in acute myeloid leukemia patients as early as 1 month after transplant is linked to a higher risk of their cancer returning. This early detection could mean improved survival rates: ow.ly/qG1q50V6hwM #onhealth

Friendly reminder of today's seminar! We hope to see you there!

I am excited to share our latest study on alloSCT for relapsed/refractory Hodgkin lymphoma (HL) at Hamilton Health Sciences, led by Alejandro Horton. mdpi.com/3188138 #mdpicurroncol via Current Oncology

New review in Int. J. Cancer! 🔬 Joint work by the Working Group ‘Clinical & Translational Epigenetics’ on emerging chromatin-targeting therapies in cancer. Proud to collaborate with amazing colleagues! #Epigenetics #DGHO onlinelibrary.wiley.com/doi/full/10.10…